Saumya Das, MD, PhD is a Professor of Medicine at Harvard Medical School, a faculty member of the Cardiac Arrhythmia Service and the co-Director of the Arrhythmia Genetics Clinic at Massachusetts General Hospital. He graduated summa cum laude in Biology from Harvard College. He completed his MD-PhD training at Harvard Medical School with his PhD in neurobiology in 2000. Following residency in internal medicine and fellowship training in cardiovascular disease and clinical cardiac electrophysiology at MGH. His research has focused on extracellular vesicles and their cargo RNAs as biomarkers in cardiometabolic disease, functional characterization of non-coding RNAs in heart disease, and RNA-based therapeutics. He has served as a co-chair of the steering committee of the NIH Extracellular Communication Consortium. He was inducted in the American Society of Clinical Investigation in 2020 and received an NIH EIA award. He is the co-founder of Thryv Therapeutics.